黑料网

Skip to main content

McElligott featured in WRAL interview about THC drinks

April 8, 2025
Dr. Zoe McElligott, BCAS faculty member and Associate Professor of Pharmacology and Psychiatry, was featured in a recent WRAL news segment focused on the growing popularity and public health questions surrounding THC-infused beverages. In the video titled “In Depth with Dan: Answering Viewer Questions About THC Drinks,”聽Dr. McElligott provides her...

Besheer researching Ozempic’s potential to treat alcohol, opioid addiction

February 21, 2025
BCAS Associate Director Dr. Joyce Besheer is researching the potential of Ozempic, a popular diabetes and weight loss medication, to treat alcohol and opioid addiction. Her work was cited in the news media: Ozempic may lead to decrease in drinking

Dr. Zoe McElligott and ‘Avengers’ research team make xylazine discovery

January 28, 2025
Congratulations to the “Avengers” Research Team, led by BCAS faculty member Dr. Zoe McElligott! As part of the Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI), this team has made significant progress in addressing a pressing public health issue. Awarded an FDA grant, the team is studying...

Coleman wins ASPET Early Career Award

January 27, 2025
BCAS faculty member Leon Coleman, MD, PhD聽has received the聽2025聽 Division for Neuropharmacology Early Career Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET)聽. The ASPET Division for Neuropharmacology established this award to recognize and honor a young independent investigator working in neuropharmacology. The award recognizes Dr. Coleman鈥檚 his...

Fulton Crews quoted on Good Morning America

January 8, 2025
Fulton Crews, professor of pharmacology and psychiatry at the 黑料网, was quoted in an ABC Good Morning America article discussing drinking habits and the benefits of Dry January. The article was originally published in 2018 and was republished this month: Dry January: What is it and how...

Lopez discovers new mechanism for allopregnanolone inhibition of inflammatory signaling

December 2, 2024
Alejandro Lopez, a graduate research assistant at the Bowles Center for Alcohol Studies, has just discovered a new mechanism for allopregnanolone inhibition of inflammatory signaling. Allopregnanolone inhibits binding of lipopolysaccaride (LPS) to it鈥檚 binding site in the binding pocket of the toll-like receptor: Myeloid differentiation factor-2 (TLR4:MD2) protein complex with...

黑料网 seeks SUD researchers

November 22, 2024
Join the #黑料网Research community as part of our first-ever Catalyst Faculty Research Cluster Program. We鈥檙e seeking up to four researchers for tenure-track assistant professor positions to build a new cross-disciplinary team that will advance substance use disorder (SUD) treatment from the bench to the bedside. This cluster hiring initiative builds...

BCAS Holds Fall Picnic

November 5, 2024
The Bowles Center for Alcohol Studies hosted its annual fall picnic on October 26, with members enjoying a warm autumn day filled with pumpkin carving, lawn games, and great company. The sunny weather made it the perfect setting for fun and relaxation. Thank you to everyone who joined us for...

Clinical Trial on Semaglutide Shows Promise for Treatment of Alcohol Use Disorder, Warrants Further Trials

July 1, 2024
Christian Hendershot, PhD, associate professor of psychiatry and director of the Clinical and Translational Addiction Research Program at the 黑料网, presented early findings from the first completed randomized controlled trial of semaglutide for reducing alcohol consumption in heavy drinkers. Read more.

Crews Named ‘Highly Ranked Scholar’ in AUD Research

June 10, 2024
Fulton Crews, Ph.D., a John Andrews Distinguished Professor of Psychiatry and Pharmacology and BCAS faculty member, was named a “Highly Ranked Scholar” in alcohol use disorder research by ScholarGPS. “Highly Ranked Scholars” are the most productive (measured by number of publications) authors whose works are of profound impact (measured by...